BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 11898471)

  • 21. Multidrug therapy: reply to letters.
    Ji B
    Lepr Rev; 1999 Sep; 70(3):367-8. PubMed ID: 10603729
    [No Abstract]   [Full Text] [Related]  

  • 22. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN
    Indian J Lepr; 1998; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract]   [Full Text] [Related]  

  • 23. Rate of relapse and reactions in MB leprosy patients after 24 and 12 months of MDT in Maharashtra.
    Deshpande J; Chougule SG; Thakar UH; Revankar CR
    Indian J Lepr; 2004; 76(3):229-30. PubMed ID: 15835608
    [No Abstract]   [Full Text] [Related]  

  • 24. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the orofacial and dental status of a population of leprosy patients treated with multidrug therapy in Senegal].
    Diallo B; Bourgeois D; Coudert JL
    Acta Leprol; 1992; 8(1):11-5. PubMed ID: 1523961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An 8-12 year follow-up of highly bacillated Indian leprosy patients treated with WHO multi-drug therapy.
    Desikan KV; Sundaresh P; Tulasidas I; Rao PV
    Lepr Rev; 2008 Sep; 79(3):303-10. PubMed ID: 19009979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin smear examination in relation to multidrug therapy campaigns.
    Bhatia VN
    Indian J Lepr; 1987; 59(1):75-9. PubMed ID: 3302062
    [No Abstract]   [Full Text] [Related]  

  • 29. A study on trend of relapse in leprosy and factors influencing relapse.
    Ali MK; Thorat DM; Subramanian M; Parthasarathy G; Selvaraj U; Prabhakar V
    Indian J Lepr; 2005; 77(2):105-15. PubMed ID: 16044808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The difficult decision when to discontinue multidrug therapy in leprosy.
    Kato L
    Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term relapse risk of multibacillary leprosy after completion of 2 years of multiple drug therapy (WHO-MDT) in Cebu, Philippines.
    Balagon MF; Cellona RV; Cruz Ed; Burgos JA; Abalos RM; Walsh GP; Saunderson PR; Walsh DS
    Am J Trop Med Hyg; 2009 Nov; 81(5):895-9. PubMed ID: 19861628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relapse after MDT in MB cases.
    Ganapati R; Pad VV
    Indian J Lepr; 1995; 67(3):334-5. PubMed ID: 8576614
    [No Abstract]   [Full Text] [Related]  

  • 34. Blister calendar packs--potential for improvement in the supply and utilization of multiple drug therapy in leprosy control programs.
    Georgiev GD; McDougall AC
    Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):603-10. PubMed ID: 3221116
    [No Abstract]   [Full Text] [Related]  

  • 35. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future trends in the treatment of leprosy.
    Pattyn SR
    Trop Geogr Med; 1994; 46(2):85-8. PubMed ID: 8079396
    [No Abstract]   [Full Text] [Related]  

  • 37. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D
    Indian J Lepr; 1998; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract]   [Full Text] [Related]  

  • 38. Multidrug therapy in the control of leprosy. A field study.
    Becx-Bleumink M
    Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385
    [No Abstract]   [Full Text] [Related]  

  • 39. Ulnar nerve abscess and relapse in a patient with indeterminate leprosy 1 year after completion of multidrug therapy.
    Agrawal A; Dalal M; Makkannavar JH; Shetty JP
    Pediatr Neurosurg; 2005; 41(3):162-4. PubMed ID: 15995337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug therapy.
    Lynch P
    Lepr Rev; 1999 Mar; 70(1):70-1. PubMed ID: 10405547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.